Armistice Capital, LLC 13D and 13G filings for Clarus Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:29 pm Purchase |
2022-12-31 | 13G | Clarus Therapeutics Holdings, Inc. CRXTQ |
Armistice Capital, LLC | 2,732,169 4.990% |
279,793 (+11.41%) |
Filing |
| 2022-02-14 6:22 pm Purchase |
2021-12-31 | 13G | Clarus Therapeutics Holdings, Inc. CRXTQ |
Armistice Capital, LLC | 2,452,376 9.990% |
2,452,376 (New Position) |
Filing |